About Infinite Clinical Trials
"Infinite Clinical Trials is an independent, private company dedicated to developing the newest medical treatments. We are conducting clinical trials in accordance with good clinical practice guidelines. We partner with pharmaceutical and device companies throughout the world. We offer novel therapies to our community. Our clinical trials offer hope for people with scores of medical problems. Our research is helping to uncover better ways to treat, prevent, diagnose, and understand human disease."
Clinical Trials at Infinite Clinical Trials
During the past decade, Infinite Clinical Trials conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 12 clinical trials were completed, i.e. on
average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 12 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Infinite Clinical Trials" #1 sponsor was "Shire" with 5 trials, followed by "Allergan" with 4 trials
sponsored, "Astellas Pharma Global Development, Inc." with 2 trials sponsored, "Exact Sciences Corporation" with 2 trials sponsored and "Alexza Pharmaceuticals, Inc."
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Infinite Clinical Trials"
#1 collaborator was "Celerion" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Infinite Clinical Trials
According to Clinical.Site data, the most researched conditions in "Infinite Clinical Trials" are
"Diabetes Mellitus" (4 trials), "Gastroparesis" (4 trials), "Colorectal Cancer" (3 trials), "Crohn's Disease" (3 trials) and "Ulcerative Colitis" (3 trials). Many other conditions were trialed in "Infinite Clinical Trials" in a lesser frequency.
Clinical Trials Intervention Types at Infinite Clinical Trials
Most popular intervention types in "Infinite Clinical Trials" are "Drug" (14 trials), "Other" (7 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Ontamalimab" (4 trials), "Relamorelin" (3 trials), "fezolinetant" (2 trials) and "placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Infinite Clinical Trials
The vast majority of trials in "Infinite Clinical Trials" are
19 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Infinite Clinical Trials
Currently, there are NaN active trials in "Infinite Clinical Trials".
undefined are not yet recruiting,
3 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Infinite Clinical Trials,
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Infinite Clinical Trials, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".